|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 |
| (11) | Patento numeris | 3020414 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15190744.1 |
| Europos patento paraiškos padavimo data | 2003-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 408719 P | 2002-09-06 | US |
| (72) |
HUANG, Haichun, US
VARNUM, Brian, US
VEZINA, Chris, US
WITTE, Alison, US
QIAN, Xueming, US
MARTIN, Frank, US
ELLIOTT, Gary, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
E. R. Squibb & Sons, L.L.C., Route 206 & Province Line Road, Princeton, NJ 08540, US |
| (54) | THERAPEUTIC ANTI-IL-1R1 MONOCLONAL ANTIBODY |
| THERAPEUTIC ANTI-IL-1R1 MONOCLONAL ANTIBODY |